GlycoNAVI-Proteins is dataset of glycan and protein information. This is the content of GlycoNAVI.
Source | Last Updated |
---|---|
GlycoNAVI Proteins | November 28, 2024 |
PDB ID ▼ | UniProt ID | Title | Descriptor |
---|---|---|---|
7S6K | 7S6K | J08 fragment antigen binding in complex with SARS-CoV-2-6P-Mut2 S protein (conformation 2) | |
7S6J | P0DTC2 | J08 fragment antigen binding in complex with SARS-CoV-2-6P-Mut2 S protein (conformation 1) | |
7S6J | 7S6J | J08 fragment antigen binding in complex with SARS-CoV-2-6P-Mut2 S protein (conformation 1) | |
7S6I | P0DTC2 | SARS-CoV-2-6P-Mut2 S protein | |
7S69 | Q68F17 | N-acetylglucosamine-1-phosphotransferase (GNPT) gamma subunit (GNPTG), from clawed frog | |
7S63 | A0A1L8FIE8 | Native-form oocyte/egg Alpha-2-Macroglobulin (A2Moo) tetramer | |
7S62 | A0A1L8FIE8 | Locally refined protomer structure of native-form oocyte/egg Alpha-2-Macroglobulin (A2Moo) tetramer | |
7S5R | P0DTC2 | Crystal structure of SARS-CoV-2 receptor binding domain in complex with neutralizing antibodies CV07-287 and COVA1-16 | |
7S5R | 7S5R | Crystal structure of SARS-CoV-2 receptor binding domain in complex with neutralizing antibodies CV07-287 and COVA1-16 | |
7S5Q | P0DTC2 | Crystal structure of SARS-CoV-2 B.1.351 variant receptor binding domain in complex with neutralizing antibodies CS44 and COVA1-16 | |
7S5Q | 7S5Q | Crystal structure of SARS-CoV-2 B.1.351 variant receptor binding domain in complex with neutralizing antibodies CS44 and COVA1-16 | |
7S5P | P0DTC2 | Crystal structure of SARS-CoV-2 B.1.351 variant receptor binding domain in complex with neutralizing antibody CS23 | |
7S5P | 7S5P | Crystal structure of SARS-CoV-2 B.1.351 variant receptor binding domain in complex with neutralizing antibody CS23 | |
7S4S | P0DTC2 | Crystal Structure of SARS-CoV-2 S receptor-binding domain (RBD) in complex CoV11 Fab | |
7S4S | 7S4S | Crystal Structure of SARS-CoV-2 S receptor-binding domain (RBD) in complex CoV11 Fab | |
7S4C | P51570 | Crystal Structure of Inhibitor-bound Galactokinase | |
7S49 | P51570 | Crystal Structure of Inhibitor-bound Galactokinase | |
7S3D | B4WP20 | Structure of photosystem I with bound ferredoxin from Synechococcus sp. PCC 7335 acclimated to far-red light | |
7S3D | B4WP21 | Structure of photosystem I with bound ferredoxin from Synechococcus sp. PCC 7335 acclimated to far-red light | |
7S3D | 7S3D | Structure of photosystem I with bound ferredoxin from Synechococcus sp. PCC 7335 acclimated to far-red light | |
7S3D | B4WFP8 | Structure of photosystem I with bound ferredoxin from Synechococcus sp. PCC 7335 acclimated to far-red light | |
7S3D | B4WSJ5 | Structure of photosystem I with bound ferredoxin from Synechococcus sp. PCC 7335 acclimated to far-red light | |
7S3D | B4WP24 | Structure of photosystem I with bound ferredoxin from Synechococcus sp. PCC 7335 acclimated to far-red light | |
7S3D | B4WP23 | Structure of photosystem I with bound ferredoxin from Synechococcus sp. PCC 7335 acclimated to far-red light | |
7S3D | B4WP25 | Structure of photosystem I with bound ferredoxin from Synechococcus sp. PCC 7335 acclimated to far-red light | |
7S3D | B4WL17 | Structure of photosystem I with bound ferredoxin from Synechococcus sp. PCC 7335 acclimated to far-red light | |
7S3D | B4WP22 | Structure of photosystem I with bound ferredoxin from Synechococcus sp. PCC 7335 acclimated to far-red light | |
7S3D | B4WFX2 | Structure of photosystem I with bound ferredoxin from Synechococcus sp. PCC 7335 acclimated to far-red light | |
7S2S | 7S2S | nanobody bound to Interleukin-2Rbeta | |
7S2S | P14784 | nanobody bound to Interleukin-2Rbeta | |
7S2R | P31785 | nanobody bound to IL-2Rg | |
7S2R | 7S2R | nanobody bound to IL-2Rg | |
7S2P | Q4E4E1 | Crystal structure of the F337L mutation of Trypanosoma cruzi glucokinase in complex with inhibitor CBZ-GlcN | |
7S1W | Q6JC62 | The AAVrh.10-glycan complex | |
7S1B | P03231 | Crystal structure of Epstein-Barr virus glycoproteins gH/gL/gp42-peptide in complex with human neutralizing antibodies 769C2 and 770F7 | |
7S1B | P03212 | Crystal structure of Epstein-Barr virus glycoproteins gH/gL/gp42-peptide in complex with human neutralizing antibodies 769C2 and 770F7 | |
7S1B | P0C6Z5 | Crystal structure of Epstein-Barr virus glycoproteins gH/gL/gp42-peptide in complex with human neutralizing antibodies 769C2 and 770F7 | |
7S1B | 7S1B | Crystal structure of Epstein-Barr virus glycoproteins gH/gL/gp42-peptide in complex with human neutralizing antibodies 769C2 and 770F7 | |
7S13 | Q3U0X8 | Crystal structure of Fab in complex with mouse CD96 dimer | |
7S13 | 7S13 | Crystal structure of Fab in complex with mouse CD96 dimer | |
7S11 | Q3U0X8 | Crystal structure of Fab in complex with mouse CD96 monomer | |
7S11 | 7S11 | Crystal structure of Fab in complex with mouse CD96 monomer | |
7S0Z | M4NKV9 | Structures of TcdB in complex with R-Ras | |
7S0Z | P10301 | Structures of TcdB in complex with R-Ras | |
7S0Q | P08069 | Head region of a complex of IGF-I with the ectodomain of a hybrid insulin receptor / type 1 insulin-like growth factor receptor | |
7S0Q | P06213 | Head region of a complex of IGF-I with the ectodomain of a hybrid insulin receptor / type 1 insulin-like growth factor receptor | |
7S0Q | P05019 | Head region of a complex of IGF-I with the ectodomain of a hybrid insulin receptor / type 1 insulin-like growth factor receptor | |
7S0K | M1V8A6 | HAP2 from Cyanidioschyzon merolae | |
7S0I | A0A0X9QTS2 | CRYSTAL STRUCTURE OF N1 NEURAMINIDASE FROM A/Michigan/45/2015(H1N1) | |
7S0C | P0DTC2 | Structure of the SARS-CoV-2 S 6P trimer in complex with neutralizing antibody N-612-017 |
GlyCosmos is a member of the GlySpace Alliance together with GlyGen and Glycomics@ExPASy.
Supported by JST NBDC Grant Number JPMJND2204
Partly supported by NIH Common Fund Grant #1U01GM125267-01
GlyCosmos Portal v4.0.0
Last updated: August 19, 2024